Update from World Conference on Lung Cancer 2016 (Mesothelioma Track) – Day 2
Results from studies using PDL1 inhibitors Today, at the World Conference on Lung Cancer 2016 (Mesothelioma Track), several investigators presented data for their immunotherapy studies.